Centene got hit hard after the big 2025 reset, and now the stock feels like a turnaround bet. The main question is whether management can fix ACA margins, stabilize Medicaid costs, and rebuild trust with investors.
Is this just a cheap stock after a bad year, or is the business still too messy to touch?
There are no replies in this thread yet. Be the first to post a reply below: